糖心传媒

Research by a team of Vanderbilt University Medical Center (VUMC) scientists suggests that older people whose hearts pump less blood have blood flow reductions in the temporal lobe regions of the brain, where Alzheimer鈥檚 pathology first begins. Read More

Three years ago Reece Dean, of Nashville鈥檚 Bellevue community, retired at age 69 from a career as a busy truck driver. Mary Ann, his wife, began to notice some changes in his memory and behavior since he was home more consistently. Read More

An enzyme that produces bioactive fatty acids has elevated activity in patients with rheumatoid arthritis, supporting further studies to understand its biologic roles in the disease. Read More

Neighborhood determinants 鈥� represented by census tract data 鈥� contribute to the risk of influenza hospitalization and could be used to guide interventions such as vaccinations to high-risk areas. Read More

A noninvasive MRI technique may help predict a troubling side effect of common medications for Parkinson鈥檚 Disease and improve clinical treatment plans. Read More

Researchers at Vanderbilt University Medical Center are leading an international effort to develop a universal influenza vaccine that would protect everyone against all strains of the flu anywhere in the world. Read More

Vanderbilt researcher Tonia Rex, Ph.D., is accustomed to performing studies in her lab with a goal of translating the findings into better diagnoses and treatment tools for the visually impaired. Read More

Collaboration between a mechanical engineer at Vanderbilt University and a pulmonologist at Vanderbilt University Medical Center (VUMC) has resulted in a National Institutes of Health (NIH) R01 grant that will be used to develop a steerable robotic needle to safely biopsy hard-to-reach lung nodules. Read More

Vanderbilt-Ingram Cancer Center (VICC) has received $2.3 million to fund a clinical research trial testing a combination of three immunotherapy compounds for patients with a specific type of advanced breast cancer. Read More

Ren茫 A. S. Robinson鈥檚 interest in aging dates back to her childhood. Her mother spent her spare time as a caregiver attending to elderly people with dementia. Now an analytic chemist, Robinson is investigating the science behind this very human condition. She is employing the emerging field of proteomics to study the process of aging as well as neurodegenerative diseases like Alzheimer鈥檚. Read More

Clinical and translational research at Vanderbilt University Medical Center (VUMC)鈥坕s thriving. Read More

Calcium intake appears to protect against colorectal cancer in individuals with certain gene variants, Vanderbilt researchers have discovered. Read More

Understanding sex differences in pain perception could lead to more targeted and effective pain assessment and management strategies in older adults with Alzheimer鈥檚 disease. Read More

Vanderbilt investigators have developed a new mouse model of kidney fibrosis, which provides a platform for identifying new targets and treatment strategies. Read More

Vanderbilt investigators have discovered a class of compounds that inhibit a mediator of inflammation and autoimmune disorders, and that could pave the way for development of future therapies. Read More

Scott Smith, M.D., Ph.D., assistant professor of Medicine, has received a 2017 research award from the Stanley Cohen Innovation Fund to test a new therapeutic strategy for peanut allergies. Smith's research could fundamentally change allergy treatment. Read More

Researchers in the Vanderbilt Institute for Global Health (VIGH) have received two new grants from the National Institutes of Health (NIH) aimed at reducing the risk of kidney disease in HIV-infected adults and improving the treatment of epilepsy in children in Nigeria. Read More

Nine more volunteers are needed to complete a study at Vanderbilt University Medical Center (VUMC) that could lead to a way to prevent the spread of HIV (human immunodeficiency virus). Read More

Nashville Mayor Megan Barry will speak during a 鈥渟cience day,鈥� Tuesday, Oct. 17, at the Belcourt Theatre hosted by the Vanderbilt Center for Addiction Research (VCAR). Read More

A compound identified at Vanderbilt represents a new lead for treating rare, aggressive childhood cancers called Ewing sarcomas. Read More